Invest Clin 63(3): 262 - 274, 2022 https://doi.org/10.54817/IC.v63n3a05
Corresponding author: Flor H Pujol. Laboratorio de Virología Molecular, Centro de Microbiología y Biología Celu-
lar, Instituto Venezolano de Investigaciones Científicas, Caracas, Miranda, Venezuela. E-mail: fhpujol@gmail.com
Sub-lineages of the Omicron variant
of SARS-CoV-2: characteristic mutations
and their relation to epidemiological
behavior.
José Luis Zambrano1, Rossana C Jaspe2, Mariana Hidalgo3, Carmen L Loureiro2,
Yoneira Sulbarán2, Zoila C Moros1, Domingo J Garzaro2, Esmeralda Vizzi4,
Héctor R Rangel2, Ferdinando Liprandi4, and Flor H Pujol2
1Laboratorio de Virología Celular, Centro de Microbiología y Biología Celular,
Instituto Venezolano de Investigaciones Científicas, Caracas, Miranda, Venezuela.
2Laboratorio de Virología Molecular, Centro de Microbiología y Biología Celular,
Instituto Venezolano de Investigaciones Científicas, Caracas, Miranda, Venezuela.
3Laboratorio de Inmunoparasitología, Centro de Microbiología y Biología Celular,
Instituto Venezolano de Investigaciones Científicas, Caracas, Miranda, Venezuela.
4Laboratorio de Biología de Virus, Centro de Microbiología y Biología Celular,
Instituto Venezolano de Investigaciones Científicas, Caracas, Miranda, Venezuela.
Key words: COVID-19; SARS-CoV-2; Omicron Variant of Concern; mutations; tropism.
Abstract. By the end of 2021, the Omicron variant of SARS-CoV-2, the
coronavirus responsible for COVID-19, emerges, causing immediate concern,
due to the explosive increase in cases in South Africa and a large number of
mutations. This study describes the characteristic mutations of the Omicron
variant in the Spike protein, and the behavior of the successive epidemic waves
associated to the sub-lineages throughout the world. The mutations in the
Spike protein described are related to the virus ability to evade the protec-
tion elicited by current vaccines, as well as with possible reduced susceptibil-
ity to host proteases for priming of the fusion process, and how this might be
related to changes in tropism, a replication enhanced in nasal epithelial cells,
and reduced in pulmonary tissue; traits probably associated with the apparent
reduced severity of Omicron compared to other variants.
Omicron variant 263
Vol. 63(3): 262 - 274, 2022
Sub-linajes de la variante Ómicron del SARS-CoV-2: mutaciones
características y su relación con el comportamiento
epidemiológico.
Invest Clin 2022; 63 (3): 262 – 274
Palabras clave: COVID-19; SARS-CoV-2; variante de preocupación Ómicron;
mutaciones; tropismo.
Resumen. A finales de 2021 surge la variante Omicron del SARS-CoV-2, el
coronavirus responsable de la COVID-19, causando preocupación inmediata,
debido al aumento explosivo de casos en Suráfrica, y a su gran cantidad de
mutaciones. Este estudio describe las mutaciones características de la variante
Ómicron en la proteína de la Espiga (S) y el comportamiento de las sucesivas
olas epidémicas asociadas a la circulación de sus sub-linajes en todo el mundo.
Las mutaciones en la proteína S descritas están relacionadas con su capacidad
para evadir la protección provocada por las vacunas actuales, así como su posi-
ble susceptibilidad reducida a las proteasas del hospedero para la preparación
del proceso de fusión. Se infiere cómo esto podría estar relacionado con su
cambio en el tropismo, con una replicación mayor en las células epiteliales
nasales y menor en el tejido pulmonar, rasgos probablemente asociados a su
aparente menor gravedad en comparación con otras variantes.
Received: 10-07-2022 Accepted: 22-07-2022
INTRODUCTION
SARS-CoV-2 infection, responsible for
the COVID-19 pandemic, has caused more
than 550 million cases and more than 6
million deaths worldwide until June 2022.
This virus belongs to the family Coronaviri-
dae. This family comprises enveloped virus-
es, with a positive sense genome of around
30,000 nt. In the case of SARS-CoV-2, the
genome codes for four structural proteins
(nucleocapsid or N, spike or S, membrane
or M and envelope or E), 15 non-structural
proteins and eight accessory proteins. The S
protein contains two regions: S1, which in-
cludes the receptor-binding domain (RBD),
and S2, with the furin-cleavage site and the
fusion peptide. RBD, specifically the receptor
binding motif (RBM), is the region respon-
sible for the attachment to the angiotensin-
converting enzyme 2 (ACE2) cellular recep-
tor (Fig. 1)1,2. Two other putative receptors
(Asialoglycoprotein Receptor 1 - ASGR1- and
KREMEN1) have been described recently for
SARS-CoV-2, which are not used by the previ-
ous SARS-CoV. The virus appears to interact
with these two additional receptors through
the RBD and also with N-terminal domain of
the S1 region3,4. These new candidates add
to the list of other potential ligands that
may interact with SARS-CoV-25,6.
During these two years of a high rate
of replication, this virus has accumulated
several mutations, allowing for its clas-
sification in more than 2000 lineages by
June 20227-9. Some of these lineages were
denominated as variants by WHO10. These
variants (lineages of viruses sharing partic-
ular types of mutations) emerged since the
end of 2020, and were defined as Variants
Under Monitoring (VUM), Variants of Inter-
est (VOI), and Variants of Concern (VOC),
264 Zambrano et al.
Investigación Clínica 63(3): 2022
when any different phenotypic trait, such as
increased transmissibility or immune eva-
sion, among others, was suspected for the
two firsts and confirmed for the last10. Until
June 2022, five VOCs were described: Al-
pha variant, which emerged in the UK (lin-
eage B.1.1.7), Beta variant in South Africa
(B.1.351), Gamma variant in Brazil (P1),
Delta variant in India (B.1.617.2), and Omi-
cron variant, first identified in South Africa
(B.1.1529). The last one was included in
the list of VOCs very soon after its identi-
fication. By the end of June, only the Omi-
cron VOC and its sub-lineages were present
as a VOC10.
This variant caused immediate concern,
due to the explosive increase in cases in
South Africa11, and the large number of mu-
tations exhibited by this new lineage. In this
study, we describe the characteristic muta-
tions of the Omicron variant of SARS-CoV-2,
and the behavior of the epidemic waves as-
sociated with the dissemination of the differ-
ent sub-lineages throughout the world.
MATERIALS AND METHODS
Description of the mutations charac-
teristic of each sub-lineage of Omicron.
The identification of characteristic muta-
Fig. 1. Mutations of the SARS-CoV-2 Omicron VOC sub-lineages. Venn diagram showing common mutations
between the SARS-CoV-2 Omicron VOC sub-lineages.